Despite evidence from preclinical studies suggesting a pivotal role for the PRR in cardiovascular diseases (Shan et al., 2010; Li et al., 2012; Huber et al., 2015; Souza et al., 2019), the clinical importance of the PRR in the PVN and RVLM has yet to be defined. This evidence concerns the gene ATP6AP2 and cardiovascular disorder.